Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02640235 · ClinicalTrials.gov registry record · NA
Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding
A NA study, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- NA
- Development phase
- 260
- Enrollment target
NCT02640235: Completed NA study, sponsored by Baxter Healthcare Corporation.
NCT02640235 is a NA study that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 260 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02640235, a NA study, has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 260 participants
- Enrollment target
Study Summary
The study is to evaluate the effectiveness and safety of CELSTAT vs active control.
Primary Outcome
Hemostasis is a process to prevent and stop bleeding within damaged blood vessels. Once the product(s) is applied it absorbs blood, turns brown, and adheres to the wound, thereby preventing thrombocytes from being washed out and accelerating hemostasis. Target bleeding sites include mild to moderate parenchymal (organ tissue),vascular (small arteries or veins or surgical reconnections) and soft tissue (muscle, fat, ligament, connective tissue) bleeding.
Interventions
- DEVICE CELSTAT
- DEVICE Surgicel Original
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2016-02-24 |
| Est. Completion | 2017-10-18 |
| Phase | NA |
What the finished NCT02640235 record still lists
NCT02640235 is an interventional study that assigns participants to a tested intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which CELSTAT is the first listed.
NCT02640235 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02640235 about?
NCT02640235 is a clinical study titled "Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding". The study is to evaluate the effectiveness and safety of CELSTAT vs active control.
What is the current status of trial NCT02640235?
This trial is currently completed. It is a NA study. The enrollment target is 260 participants. The study started on 2016-02-24. Estimated completion is 2017-10-18.
What interventions are being tested in trial NCT02640235?
The interventions under investigation include: CELSTAT (DEVICE), Surgicel Original (DEVICE).
Who is sponsoring clinical trial NCT02640235?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02640235's enrollment target sits among peer trials
260 397th of 2000 higher than 1,601 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI